Why patients should be more empowered: a European perspective on lessons learned in the management of diabetes
- PMID: 21129355
- PMCID: PMC3005070
- DOI: 10.1177/193229681000400634
Why patients should be more empowered: a European perspective on lessons learned in the management of diabetes
Abstract
Patient empowerment has emerged as a new paradigm that can help improve medical outcomes while lowering costs of treatment. The concept seems particularly promising in the management of chronic diseases. Diabetes may provide a blueprint for implementing patient empowerment because empowering patients has been instrumental in achieving the successes we have witnessed in the management of diabetes in recent decades. Looking at the example of diabetes, this article investigates the role and contribution of patient empowerment to therapy success and derives actions that need to be taken in order to fully leverage the potential of this concept for patients, health care professionals, and health systems.
© 2010 Diabetes Technology Society.
References
-
- Vassiliou A. European Patient’s Rights Day. Speech presented at: European Union Patient’s Rights Day; April 22, 2009; Strasbourg, Austria. Available from: http://ec.europa.eu/dgs/health_consumer/dyna/mailbox/index_en.cfmon.
-
- Monteagudo Pena JL, Moreno Gil O. e-Health for patient empowerment in Europe. Madrid: Instituto de Salud Carlos III; 2007. Available from: http://ec.europa.eu/information_society/activities/health/docs/publicati....
-
- Guerci B, Drouin P, Grangé V, Bougnères P, Fontaine P, Kerlan V, Passa P, Thivolet Ch, Vialettes B, Charbonnel B, ASIA Group Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29(7614):587–594. - PubMed
-
- Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, Imamoglu S, Perusicová J, Uliciansky V, Winkler G. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study) Diabetes Obes Metab. 2008;10(12):1239–1247. - PubMed
-
- Martin S, Schneider B, Heinemann L, Lodwig V, Kurth HJ, Kolb H, Scherbaum WA. Self-monitoring of blood glucose in type 2 diabetes and long-term outcome: an epidemiological cohort study. Diabetologia. 2006;49(2):271–278. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
